Assessing the yellow fever outbreak in Angola
A joint ECDC–European Commission mission team was sent to Angola to review the epidemiological situation of yellow fever in Angola, assess the implemented control measures, evaluate the risk of importation of yellow fever to the EU, assess the risk for EU citizens, and provide advice to the Angolan government and the European Commission. This report summarises the results of the mission.
The mission was initiated by the European Commission and ECDC in agreement with the Government of the Republic of Angola. The deployment of the expert team took place in the framework of the European Union Civil Protection Mechanism and employed the newly established European Medical Corps.
n this context, from 10 to 20 May 2016 the European Commission and ECDC deployed a team of public health and humanitarian experts in Angola. The mission team reviewed the epidemiological situation, assessed the implemented control measures (to later advise the Angolan health authorities), evaluated the risk of importation of yellow fever to the EU, assessed the risk for EU citizens, and provided advice to the European Commission.
Although the number of new reported cases has decreased over recent weeks and a mass vaccination campaign reached about half of the targeted population, the outbreak is still ongoing and can’t yet be considered under control. Local transmission is being reported in many areas of the country. Large urban areas and provinces such as Cabinda represent a high risk for international spread.
Risk to EU/EEA
Travellers coming from affected areas may not have been vaccinated against yellow fever and may therefore arrive in the EU/EEA creating a risk for the potential local transmission of the disease in areas where the vector is present.In order to avoid exportation of yellow fever virus to other countries, individuals should only be allowed to enter and leave Angola if valid vaccination records are produced. At the time of writing this assessment, implementation of this strategy was currently absent or performed in a limited way. The risk of establishment of yellow fever transmission in the EU/EEA is low, even in areas where the primary vector Aedes aegypti ispresent.
The mission was organised in agreement with the Government of Angola and in close coordination with the World Health Organization. The mission was conducted in the framework of the European Union Civil Protection Mechanism and, for the first time, employed the newly established European Medical Corps.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Third update.
16 Mar 2018 - In September 2017, the Ministry of Health in Brazil declared the end of the 2016–2017 yellow fever outbreak in the country. The upsurge of human cases since December 2017 and the continuous non-human primate epizootics since September 2017 indicate a continued or resumed increase in yellow fever virus circulation in Brazil. Since January 2018, most of the yellow fever cases have been reported from São Paulo, Rio de Janeiro and Minas Gerais states.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Second update
18 Jan 2018 - This publication assesses the risk to EU/EEA countries and citizens associated with the ongoing outbreak of yellow fever in Brazil. This is the second update of a rapid risk assessment originally produced on 25 January 2017 and updated on 13 April 2017.